Unfractioned Heparin for Treatment of Sepsis Caused by Abdominal Infection

Clinical trial NCT04861922 · UNKNOWN

Trial details

NCT number: NCT04861922
Sponsor: The Third Xiangya Hospital of Central South University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Sepsis Gram-Negative Bacterial Infections Heparin

Start date: 2021-05-11
Primary completion: 2023-12-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.